A restrictive stance on mergers and acquisitions stifles the entire startup ecosystem by removing viable exit paths. Allowing M&A to flourish provides the liquidity events that encourage venture capitalists to deploy risk capital into the next generation of innovative companies.

Mergers and acquisitions are more than just exits for private biotech companies. They are the primary mechanism for returning capital to venture capitalists and LPs, who then reinvest those funds back into the ecosystem, fueling the next generation of innovative startups.

With hundreds of unicorns and only about 20 tech IPOs per year, the market has a 30-year backlog. Consolidations between mid-size unicorns, like the potential Fivetran and dbt deal, are a necessary strategy for VCs to create IPO-ready companies and generate much-needed liquidity from their portfolios.

A cohort of high-valuation SaaS companies is now stuck, not growing fast enough for an IPO with a frozen M&A market. This "SaaS Apocalypse" traps billions in paper gains that can't be returned to investors, stalling the entire venture ecosystem.

Private equity provides essential exit opportunities for founders, which incentivizes innovation. If PE firms mismanage acquisitions like Pizza Hut, leading to their failure, it's a sign of a healthy market, not a broken system. Dying companies make way for new ones.

Successful acquisitions don't just benefit the acquired company's investors. These investors often reinvest their profits into new, earlier-stage ventures, providing crucial capital that fuels the entire biotech ecosystem's growth and innovation.

The current M&A wave is unique because it includes both public and private company takeouts. This creates a robust capital recycling engine, providing quick returns to VCs (from private sales) and public specialist funds (from public takeouts). This capital is then immediately redeployed into new early and later-stage companies, sustaining the innovation ecosystem.

M&A is driven by CEO confidence, which is heavily influenced by the regulatory environment. A subtle shift in regulatory posture from a definitive 'no' to a 'maybe' is enough to unlock massive pent-up demand for transformative deals, potentially leading to a historic year for M&A.

The Brex acquisition is vital for the VC ecosystem. Venture funds have struggled to raise new capital because a lack of IPOs and M&A prevents them from returning cash to their LPs (like universities). This deal helps restart that crucial cycle of exits enabling new investments.